Request Deal Involvement
Sumitovant Biopharma to acquire a 28% stake in Urovant Sciences for $191m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
O'Melveny & Myers
legal advisors to financial advisors
Skadden Arps Slate Meagher & Flom
pr advisors
Jeff Winton Associates
financial advisors
Lazard
financial advisors
Citigroup
legal advisors
Jones Day
or
Principals
target
UROVANT SCIENCES
bidder
SUMITOVANT BIOPHARMA
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite